Hereditary Retinoblastoma Test (RB1 sequencing and deletion/duplication) method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
Retinoblastoma Test method(s): ◦ Sequencing, Capillary (Sanger) Impact Genetics - Bowmanville, Canada |
Retinoblastoma Test method(s): ◦ Mutation Scanning of Entire Coding Region Impact Genetics - Bowmanville, Canada |
Retinoblastoma Test method(s): ◦ Genotyping (Microarray, Beads, etc.) Impact Genetics - Bowmanville, Canada |
Retinoblastoma Test method(s): ◦ Linkage Analysis Impact Genetics - Bowmanville, Canada |
Retinoblastoma Test method(s): ◦ Del/Dup (CNV) Impact Genetics - Bowmanville, Canada |
Retinoblastoma Test method(s): ◦ Sequencing, Capillary (Sanger) University of Pennsylvania School of Medicine, Genetic Diagnostic Laboratory - Philadelphia, PA, USA |
Retinoblastoma Test method(s): ◦ Linkage Analysis University of Pennsylvania School of Medicine, Genetic Diagnostic Laboratory - Philadelphia, PA, USA |
Retinoblastoma Test method(s): ◦ Methylation Analysis University of Pennsylvania School of Medicine, Genetic Diagnostic Laboratory - Philadelphia, PA, USA |
Retinoblastoma Test method(s): ◦ Del/Dup (CNV) University of Pennsylvania School of Medicine, Genetic Diagnostic Laboratory - Philadelphia, PA, USA |
Retinoblastoma: RB1 Gene Deletion/Duplication method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
Inflammatory Bowel Disease: Sequencing Panel method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
Retinoblastoma: RB1 Gene Sequencing method(s): Emory University School of Medicine, Emory Molecular Genetics Laboratory - Atlanta, GA, USA |
Sanger sequencing of the RB1 gene method(s): ◦ Mutation Scanning of Entire Coding Region ◦ Sequencing, Capillary (Sanger) Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Detection of large deletions and/or duplications in the RB1 gene by MLPA method(s): ◦ Del/Dup (CNV) Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain |
Retinoblastoma Test (the RB1 gene- MLPA analysis) method(s): ◦ Del/Dup (CNV) GENESIS Center for Medical Genetics, Laboratory of Molecular Genetics - Poznan, Poland |
Retinoblastoma, Deletions-Duplications (MLPA) RB1 Gene method(s): ◦ Del/Dup (CNV) Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Retinoblastoma, Sequencing RB1 Gene method(s): ◦ Sequencing, Capillary (Sanger) Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Hereditary Cancer Panel 170 PLUS method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Hereditary Cancer Panel 'For Her' method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 94 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
CancerNext - Expanded method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
Oncology, Panel method(s): ◦ Sequencing, Next Gen GENETAQ, Molecular Genetics Centre - Malaga, Spain |
Hereditary Cancer Syndromes, Comprehensive Diagnostics method(s): ◦ Sequencing, Next Gen MGZ München, Medizinisch Genetisches Zentrum München - München, Germany |
Familial Tumor Syndromes Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
Familial Melanoma Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
Targeted Somatic Cancer Panel Sequencing (TSP50) method(s): ◦ Sequencing, Next Gen Genomics for Life APA 1164 - Herston, Queensland, Australia |
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes method(s): ◦ Microarray (CGH-Oligo, SNP, BAC) ◦ Sequencing, Next Gen ARUP Laboratories, Molecular Genetics Laboratory - Salt Lake City, UT, USA |
NewbornDx method(s): ◦ Sequencing, Next Gen Parabase Genomics - Boston, MA, USA |
Solid Tumor Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
CNS Tumor Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
Melanoma Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
Somatic Tumor Panel method(s): ◦ Sequencing, Next Gen CeGaT GmbH - Tübingen, Germany |
OncoRisk (NGS panel for 49 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Retinoblastoma (deletion/duplication analysis on on RB1 gene) method(s): ◦ Del/Dup (CNV) CGC Genetics - Porto, Portugal |
Retinoblastoma (methylation and deletion/duplication analysis on RB1 gene) method(s): ◦ Methylation Analysis ◦ Del/Dup (CNV) CGC Genetics - Porto, Portugal |
Retinoblastoma (sequence analysis of RB1 gene) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Retinoblastoma: RB1 Gene Deletion/Duplication method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Retinoblastoma: RB1 Gene Sequencing method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Melanoma: Sequencing Panel method(s): ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Melanoma: Deletion/Duplication Panel method(s): ◦ Del/Dup (CNV) CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
OncoRisk Plus (NGS panel for 89 genes) method(s): ◦ Sequencing, Next Gen CGC Genetics - Porto, Portugal |
Com.Pl.i.t. DX 54 genes - Comprehensive Panel for Individualized Cancer Threatment method(s): ◦ Del/Dup (CNV) ◦ Multicolor FISH (M-FISH) / Spectral Karotyping (tm) (SKY (tm)) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen GeneKor Medical S.A. - Athens, Greece |
Bladder cancer method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Colorectal neoplasia method(s): ◦ Sequencing, Next Gen Genomic Laboratory of the DNA Research Center LTD (Centrum Badań DNA sp z o.o.) - Poznań, Poland |
Cancer Predisposition method(s): ◦ Sequencing, Next Gen Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
Cutaneous Malignant Melanoma, Panel Massive Sequencing (NGS) 11 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Eye Disorders NGS Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
RB1 method(s): ◦ Sequencing, Next Gen ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) Fulgent Diagnostics - Temple City, CA, USA |
Comprehensive Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
Melanoma Cancer Comprehensive Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
Sarcoma Cancer Comprehensive Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Capillary (Sanger) ◦ Sequencing, Next Gen Fulgent Diagnostics - Temple City, CA, USA |
CustomNext-Cancer method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
TAT: 3-4 weeks price: $690.00
Retinoblastoma via the RB1 Gene method(s): ◦ Del/Dup (CNV) PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
TAT: 3-5 weeks price: $990.00
Retinoblastoma via the RB1 Gene method(s): ◦ Sequencing, Next Gen PreventionGenetics (Prevention Genetics), Clinical DNA Testing and DNA Banking - Marshfield, WI, USA |
FISH test on peripheral Blood/Bone marrow, deletion 13q method(s): ◦ FISH-Interphase Department of Cytogenetics, Dr. Lal PathLabs Ltd - New Delhi, India |
MelanomaNext method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Ambry Genetics Corp, Ambry Genetics - Aliso Viejo, CA, USA |
Retinoblastoma (RB1) Del/Dup method(s): ◦ Del/Dup (CNV) Children's Hospital of Los Angeles, Center for Personalized Medicine Laboratory - Los Angeles, CA, USA |
Retinoblastoma (RB1) Sanger Sequencing method(s): ◦ Sequencing, Capillary (Sanger) Children's Hospital of Los Angeles, Center for Personalized Medicine Laboratory - Los Angeles, CA, USA |
CEN4GEN Prostate cancer: extended gene sequencing panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Ovarian cancer: Extended sequencing panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Lung cancer: Extended Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Lung cancer: Extended Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Breast cancer: Extended Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Comprehensive Solid tumors (somatic genetic testing): Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
CEN4GEN Comprehensive targeted oncogene tumor mutation screen (somatic genetic testing): Sequencing Panel method(s): ◦ Sequencing, Next Gen CEN4GEN Institute for Genomics and Molecular Diagnostics - Edmonton, Canada |
Hereditary Retinoblastoma method(s): ◦ Sequencing, Capillary (Sanger) ◦ Del/Dup (CNV) Centogene AG, Rare Disease Company - Rostock, Germany |
Hereditary Sarcoma (Susceptibility to), Panel Massive Sequencing (NGS) 25 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
Breast Tumors Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
Gynecologic Tumors Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
Head and Neck Tumors Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
Thoracic Tumors Gene Set method(s): ◦ Sequencing, Next Gen Genomics and Pathology Services, Washington University - St. Louis, MO, USA |
CentoICU Platinum method(s): ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
Glioma (Susceptibility to Somatic), Panel Massive Sequencing (NGS) 14 Genes method(s): ◦ Sequencing, Next Gen Reference Laboratory Genetics - Hospitalet de Llobregat, Spain |
TAT: 1-3 weeks price: $1,500.00
Invitae Multi-Cancer Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Pediatric Nervous System/Brain Tumors Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Melanoma Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Sarcoma Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Pediatric Solid Tumors Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Retinoblastoma Test method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
TAT: 1-3 weeks price: $1,500.00
Invitae Nervous System/Brain Cancer Panel method(s): ◦ Sequencing, Next Gen ◦ Del/Dup (CNV) Invitae - San Francisco, CA, USA |
Retinoblastoma method(s): ◦ Sequencing, Next Gen Asper Biotech Ltd., Asper Biotech - Tartu, Estonia |
Cancer Hotspot Panel (somatic mutation analysis) method(s): ◦ Sequencing, Next Gen Centogene AG, Rare Disease Company - Rostock, Germany |
Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Hereditary Melanoma and Skin Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Hereditary Pediatric Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Hereditary Retinoblastoma Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, Helsinki - Helsinki, Finland |
Comprehensive Hereditary Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Hereditary Melanoma and Skin Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Hereditary Pediatric Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Hereditary Retinoblastoma Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Blueprint Genetics, San Francisco - San Francisco, CA, USA |
Phosphorus Pan Cancer Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
Phosphorus Pediatric Cancers Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
Phosphorus Brain and Nervous System Cancers Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |
Phosphorus Melanoma Panel method(s): ◦ Del/Dup (CNV) ◦ Sequencing, Next Gen Phosphorus Diagnostics - Livingston, NJ, USA |